| Reference : The role of synphilin-1 in synaptic function and protein degradation. |
| Scientific journals : Article | |||
| Life sciences : Genetics & genetic processes | |||
| http://hdl.handle.net/10993/17139 | |||
| The role of synphilin-1 in synaptic function and protein degradation. | |
| English | |
Krüger, Rejko  [University of Luxembourg > Faculty of Science, Technology and Communication (FSTC) > Life Science Research Unit] | |
| 2004 | |
| Cell and Tissue Research | |
| 318 | |
| 1 | |
| 195-9 | |
| Yes | |
| 0302-766X | |
| Germany | |
| [en] Carrier Proteins/genetics/metabolism ; Humans ; Nerve Tissue Proteins/genetics/metabolism ; Parkinson Disease/genetics/physiopathology ; Synapses/physiology | |
| [en] The name synphilin-1 comes from its identification as an alpha-synuclein-interacting protein (SNCAIP) in yeast two-hybrid screens. Since alpha-synuclein ( PARK1) was the first gene identified as causing inherited forms of Parkinson's disease (PD), synphilin-1 was quickly implicated in neurodegeneration in PD. Recently, the first genetic evidence for the direct contribution of synphilin-1 in the pathogenesis of PD has been defined with the identification of an R621C mutation as a susceptibility factor for PD in two German patients. Extensive in vitro studies have determined the physiological functions of synphilin-1, identified novel synphilin-1-interacting proteins, and linked synphilin-1 to ubiquitin-mediated protein degradation. The present article provides an overview of the current concepts of the role of synphilin-1 in synaptic function and protein degradation and in the molecular mechanisms leading to neurodegeneration in PD. | |
| Luxembourg Centre for Systems Biomedicine (LCSB): Clinical & Experimental Neuroscience (Krüger Group) | |
| http://hdl.handle.net/10993/17139 | |
| 10.1007/s00441-004-0953-z |
There is no file associated with this reference.
All documents in ORBilu are protected by a user license.
